Kakic, L. Et Al. 2017. Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY , vol.69 .

Kakic, L., KÜÇÜKŞAHİN, O., Ozbalkan, Z., Bes, C., YAZISIZ, V., YAZICI, A., ... SOLMAZ, D.(2017). Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY , vol.69.

Kakic, Levent Et Al. "Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis," ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Kakic, Levent Et Al. "Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis." ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Kakic, L. Et Al. (2017) . "Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis." ARTHRITIS & RHEUMATOLOGY , vol.69.

@article{article, author={Levent Kakic Et Al. }, title={Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2017}